Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 1, 2011, Pages 109-

  Deutsch, Melanie ^a   Papadopoulos, Nikolaos ^a   Manolakopoulos, Spilios ^a   Hatziyanni, Emilia ^a   Vassilopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENTECAVIR; LAMIVUDINE; PREDNISONE; RITUXIMAB; VINCRISTINE; VIRUS DNA;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MALE; MONOTHERAPY; PRIORITY JOURNAL; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; VIRUS LOAD; VIRUS REACTIVATION;

DRUG RESISTANCE, VIRAL; FATAL OUTCOME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSION; LAMIVUDINE; LYMPHOMA; MALE; MIDDLE AGED; SPLENIC NEOPLASMS; VIRAL LOAD; VIRUS ACTIVATION;

EID: 78650779658     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834124c4     Document Type: Letter

References (5)

1. European Association for the Study of Liver Disease. EASL clinical practice guidelines. J Hepatol 2009; 50:227-242.
2. Hsu C, Hsiung CA, Su IJ, Hwang WS, Wang MC, Lin SF, et al. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial. Hepatology 2008; 47:844-853.
3. Svicher V, Alteri C, Gori C, Salpini R, Marcuccilli F, Bertoli A, et al. Lamivudine-resistanct mutations can be selected even at very low levels of hepatitis B viraemia. Dig Liver Dis 2010; doi:10.1016/j.dld.2010.04.017.
4. Manolakopoulos S, Bethanis S, Koutsounas S, Goulis J, Vlachogiannakos J, Christias E, et al. Long-term therapy with adefovir dipivoxil in hepatitis B e, antigen-negative patients developing resistance to lamivudine. Aliment Pharmacol Ther 2008; 27:266-273.
5. Thabut D, Ratziu V, Bernard-Chabert B, Poynard T, Benhamou Y, Thibault V, et al. Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure. Gut 2003; 52:614.